Genus (GENSF)
PNK: GENSF
· Real-Time Price · USD
21.77
0.00 (0.00%)
At close: Apr 25, 2025, 10:08 AM
Company Description
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development.
It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
In addition, it offers technical services to farmers.
The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Genus

Country | GB |
IPO Date | Sep 11, 2009 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 3,500 |
CEO | Jorgen Kokke |
Contact Details
Address: Matrix House Basingstoke, GB | |
Website | https://www.genusplc.com |
Stock Details
Ticker Symbol | GENSF |
Exchange | PNK |
Fiscal Year | July - June |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | n/a |
ISIN Number | GB0002074580 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Jorgen Kokke | Chief Executive Officer & Director |
Alison Jane Henriksen ACA | Chief Financial Officer & Executive Director |
Dr. Matt Culbertson | Chief Operating Officer |
Jim Low | Chief Operating Officer of Genus ABS |
Andrew Thompson | Head of ABS EMEA |
Angelle R. Rosata SPHR | Chief Human Resources Officer |
Dr. Elena Rice | Head of R&D and Chief Scientific Officer |
Janet Duane | Group Financial Controller |
Lucie Mary Katja Grant | Group General Counsel & Company Secretary |
Mark Birri | Chief Corporate Development Officer |